Medizinische Hochschule Hannover (MHH) / Hannover Medical School
University / College
Location:
Hannover,
Germany (DE)
ISNI: 0000000095299877
ROR: https://ror.org/00f2yqf98
BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors (2021)
Haanen J, Mackensen A, Koenecke C, Alsdorf W, Desuki A, Wagner-Drouet E, Heudobler D, et al.
Conference contribution
Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics (2021)
Stojanović SD, Fuchs M, Liang C, Schmidt K, Xiao K, Just A, Pfanne A, et al.
Journal article
Correction to: Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn’s disease (Clinical Epigenetics, (2020), 12, 1, (1), 10.1186/s13148-019-0796-9) (2021)
Gombert S, Rhein M, Winterpacht A, Münster T, Hillemacher T, Leffler A, Frieling H
Journal article, Erratum
German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease: Report 2020-Comprehensive Data from 6 Years of Experience (2021)
Beckmann A, Dittrich S, Arenz C, Krogmann ON, Horke A, Tengler A, Meyer R, et al.
Journal article
Role of endothelial microRNA 155 on capillary leakage in systemic inflammation (2021)
Etzrodt V, Idowu TO, Schenk H, Seeliger B, Prasse A, Thamm K, Pape T, et al.
Journal article
Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease (2021)
Schiffer L, Gertges R, Nöhre M, Schieffer E, Tegtbur U, Pape L, de Zwaan M, Schiffer M
Journal article
Selective retina therapy and thermal stimulation of the retina: different regenerative properties-implications for AMD therapy (2021)
Richert E, Papenkort J, Von Der Burchard C, Klettner A, Arnold P, Lucius R, Brinkmann R, et al.
Journal article
Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021)
Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al.
Conference contribution
Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021)
Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al.
Conference contribution
Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis (2021)
Bethge WA, Martus P, Schmitt M, Holtick U, Borchmann P, Subklewe M, Rejeski K, et al.
Conference contribution